{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T18:13:00Z","timestamp":1789409580231,"version":"build-2803163510"},"reference-count":143,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019542","name":"Basic Research Project of Wenzhou City","doi-asserted-by":"publisher","award":["Y20240008"],"award-info":[{"award-number":["Y20240008"]}],"id":[{"id":"10.13039\/501100019542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970333"],"award-info":[{"award-number":["81970333"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017594","name":"Medical Science and Technology Project of Zhejiang Province","doi-asserted-by":"publisher","award":["2024KY138"],"award-info":[{"award-number":["2024KY138"]}],"id":[{"id":"10.13039\/501100017594","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007194","name":"Wenzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007194","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017528","name":"Key Discipline of Zhejiang Province in Medical Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017528","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Advanced Research"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jare.2025.03.007","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T21:19:51Z","timestamp":1741900791000},"page":"475-489","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Functions of FGF21 and its role in cardiac hypertrophy"],"prefix":"10.1016","volume":"79","author":[{"given":"Lei","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Bing","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9652-1040","authenticated-orcid":false,"given":"Guohua","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jare.2025.03.007_b0005","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","article-title":"Mechanisms of physiological and pathological cardiac hypertrophy","volume":"15","author":"Nakamura","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jare.2025.03.007_b0010","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.tig.2004.08.007","article-title":"Evolution of the Fgf and Fgfr gene families","volume":"20","author":"Itoh","year":"2004","journal-title":"Trends Genet"},{"key":"10.1016\/j.jare.2025.03.007_b0015","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0167-4781(00)00067-1","article-title":"Identification of a novel FGF, FGF-21, preferentially expressed in the liver","volume":"1492","author":"Nishimura","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jare.2025.03.007_b0020","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jcp.29879","article-title":"Relationship between FGF21 and drug or nondrug therapy of type 2 diabetes mellitus","volume":"236","author":"Guo","year":"2021","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.jare.2025.03.007_b0025","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1210\/me.2010-0142","article-title":"Research resource: Comprehensive expression atlas of the fibroblast growth factor system in adult mouse","volume":"24","author":"Fon Tacer","year":"2010","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.jare.2025.03.007_b0030","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/jcmm.14007","article-title":"Pancreatic fibroblast growth factor 21 protects against type 2 diabetes in mice by promoting insulin expression and secretion in a PI3K\/Akt signaling-dependent manner","volume":"23","author":"Pan","year":"2019","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.jare.2025.03.007_b0035","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1038\/ncomms3019","article-title":"Fibroblast growth factor 21 protects against cardiac hypertrophy in mice","volume":"4","author":"Planavila","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.jare.2025.03.007_b0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/bs.vh.2016.02.008","article-title":"The FGF21 receptor signaling complex: klothobeta, FGFR1c, and other regulatory interactions","volume":"101","author":"Kilkenny","year":"2016","journal-title":"Vitam Horm"},{"key":"10.1016\/j.jare.2025.03.007_b0045","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1530\/JOE-15-0289","article-title":"Effects of fibroblast growth factor 21 on the heart","volume":"227","author":"Tanajak","year":"2015","journal-title":"J Endocrinol"},{"key":"10.1016\/j.jare.2025.03.007_b0050","doi-asserted-by":"crossref","first-page":"E1105","DOI":"10.1152\/ajpendo.00348.2009","article-title":"Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models\u2013association with liver and adipose tissue effects","volume":"297","author":"Xu","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jare.2025.03.007_b0055","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cmet.2012.08.002","article-title":"betaKlotho is required for fibroblast growth factor 21 effects on growth and metabolism","volume":"16","author":"Ding","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/j.jare.2025.03.007_b0060","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/nm.3249","article-title":"FGF21 regulates metabolism and circadian behavior by acting on the nervous system","volume":"19","author":"Bookout","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.jare.2025.03.007_b0065","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2015.00133","article-title":"FGF21 and cardiac physiopathology","volume":"6","author":"Planavila","year":"2015","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.jare.2025.03.007_b0070","first-page":"1","article-title":"Physiological and pharmacological roles of FGF21 in cardiovascular diseases","volume":"2016","author":"Cheng","year":"2016","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.jare.2025.03.007_b0075","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1097\/CM9.0000000000001890","article-title":"The role of FGF21 in the pathogenesis of cardiovascular disease","volume":"134","author":"Zhang","year":"2021","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.jare.2025.03.007_b0080","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10741-022-10268-0","article-title":"Fibroblast growth factor 21 in heart failure","volume":"28","author":"Tucker","year":"2022","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jare.2025.03.007_b0085","doi-asserted-by":"crossref","first-page":"66","DOI":"10.7150\/ijbs.73936","article-title":"Targeting FGF21 in cardiovascular and metabolic diseases: from mechanism to medicine","volume":"19","author":"Tan","year":"2023","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.jare.2025.03.007_b0090","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.cmet.2007.05.003","article-title":"Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21","volume":"5","author":"Inagaki","year":"2007","journal-title":"Cell Metab"},{"key":"10.1016\/j.jare.2025.03.007_b0095","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1210\/en.2013-1490","article-title":"Liver-enriched transcription factor CREBH interacts with peroxisome proliferator-activated receptor alpha to regulate metabolic hormone FGF21","volume":"155","author":"Kim","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.jare.2025.03.007_b0100","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1210\/me.2014-1259","article-title":"Glucocorticoids regulate the metabolic hormone FGF21 in a feed-forward loop","volume":"29","author":"Patel","year":"2015","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.jare.2025.03.007_b0105","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.celrep.2017.09.065","article-title":"A specific ChREBP and PPARalpha cross-talk is required for the glucose-mediated FGF21 response","volume":"21","author":"Iroz","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.jare.2025.03.007_b0110","doi-asserted-by":"crossref","first-page":"14078","DOI":"10.1074\/jbc.C110.107375","article-title":"Thyroid hormone regulates hepatic expression of fibroblast growth factor 21 in a PPARalpha-dependent manner","volume":"285","author":"Adams","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jare.2025.03.007_b0115","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00125-014-3475-6","article-title":"Fibroblast growth factor 21 participates in adaptation to endoplasmic reticulum stress and attenuates obesity-induced hepatic metabolic stress","volume":"58","author":"Kim","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.jare.2025.03.007_b0120","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1007\/s00125-015-3704-7","article-title":"Disruption of mitochondrial fission in the liver protects mice from diet-induced obesity and metabolic deterioration","volume":"58","author":"Wang","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.jare.2025.03.007_b0125","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nm.3014","article-title":"Autophagy deficiency leads to protection from obesity and insulin resistance by inducing Fgf21 as a mitokine","volume":"19","author":"Kim","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.jare.2025.03.007_b0130","doi-asserted-by":"crossref","first-page":"15668","DOI":"10.1074\/jbc.M110.102160","article-title":"Regulation of FGF21 expression and secretion by retinoic acid receptor-related orphan receptor alpha","volume":"285","author":"Wang","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jare.2025.03.007_b0135","doi-asserted-by":"crossref","first-page":"25123","DOI":"10.1074\/jbc.M112.375907","article-title":"Activation of the farnesoid X receptor induces hepatic expression and secretion of fibroblast growth factor 21","volume":"287","author":"Cyphert","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jare.2025.03.007_b0140","doi-asserted-by":"crossref","first-page":"10490","DOI":"10.1074\/jbc.M112.429852","article-title":"Retinoic acid receptor beta stimulates hepatic induction of fibroblast growth factor 21 to promote fatty acid oxidation and control whole-body energy homeostasis in mice","volume":"288","author":"Li","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jare.2025.03.007_b0145","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1210\/en.2013-1758","article-title":"Orphan nuclear receptor Nur77 mediates fasting-induced hepatic fibroblast growth factor 21 expression","volume":"155","author":"Min","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.jare.2025.03.007_b0150","doi-asserted-by":"crossref","DOI":"10.3390\/cells10061298","article-title":"Th2 cytokines increase the expression of fibroblast growth factor 21 in the liver","volume":"10","author":"Kang","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jare.2025.03.007_b0155","doi-asserted-by":"crossref","first-page":"29751","DOI":"10.1074\/jbc.M114.565960","article-title":"Fibroblast growth factor 21 is regulated by the IRE1alpha-XBP1 branch of the unfolded protein response and counteracts endoplasmic reticulum stress-induced hepatic steatosis","volume":"289","author":"Jiang","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jare.2025.03.007_b0160","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1210\/me.2012-1151","article-title":"Fasting-induced FGF21 is repressed by LXR activation via recruitment of an HDAC3 corepressor complex in mice","volume":"26","author":"Archer","year":"2012","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.jare.2025.03.007_b0165","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1124\/mol.108.044826","article-title":"Adipose fibroblast growth factor 21 is up-regulated by peroxisome proliferator-activated receptor gamma and altered metabolic states","volume":"74","author":"Muise","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jare.2025.03.007_b0170","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.cell.2011.11.062","article-title":"Fibroblast growth factor-21 regulates PPARgamma activity and the antidiabetic actions of thiazolidinediones","volume":"148","author":"Dutchak","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.jare.2025.03.007_b0175","doi-asserted-by":"crossref","first-page":"12983","DOI":"10.1074\/jbc.M110.215889","article-title":"Thermogenic activation induces FGF21 expression and release in brown adipose tissue","volume":"286","author":"Hondares","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jare.2025.03.007_b0180","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1016\/j.febslet.2008.10.021","article-title":"FGF21 is an Akt-regulated myokine","volume":"582","author":"Izumiya","year":"2008","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jare.2025.03.007_b0185","article-title":"Acute exercise induces FGF21 expression in mice and in healthy humans","volume":"8","author":"Kim","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jare.2025.03.007_b0190","article-title":"Exercise increases serum fibroblast growth factor 21 (FGF21) levels","volume":"7","author":"Atkin","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jare.2025.03.007_b0195","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/jb\/mvv041","article-title":"SIRT1-related inhibition of pro-inflammatory responses and oxidative stress are involved in the mechanism of nonspecific low back pain relief after exercise through modulation of Toll-like receptor 4","volume":"158","author":"Cheng","year":"2015","journal-title":"J Biochem"},{"key":"10.1016\/j.jare.2025.03.007_b0200","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1161\/CIRCULATIONAHA.122.059631","article-title":"FGF21\u2013Sirtuin 3 axis confers the protective effects of exercise against diabetic cardiomyopathy by governing mitochondrial integrity","volume":"146","author":"Jin","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jare.2025.03.007_b0205","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1172\/JCI23606","article-title":"FGF-21 as a novel metabolic regulator","volume":"115","author":"Kharitonenkov","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jare.2025.03.007_b0210","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/hep.28523","article-title":"Fibroblast growth factor 21 improves hepatic insulin sensitivity by inhibiting mammalian target of rapamycin complex 1 in mice","volume":"64","author":"Gong","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jare.2025.03.007_b0215","article-title":"AKR-001, an Fc-FGF21 analog, showed sustained pharmacodynamic effects on insulin sensitivity and lipid metabolism in type 2 diabetes patients","volume":"1","author":"Kaufman","year":"2020","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.jare.2025.03.007_b0220","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.cmet.2016.01.006","article-title":"FGF21 lowers plasma triglycerides by accelerating lipoprotein catabolism in white and brown adipose tissues","volume":"23","author":"Schlein","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.jare.2025.03.007_b0225","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cmet.2008.06.014","article-title":"The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man","volume":"8","author":"Galman","year":"2008","journal-title":"Cell Metab"},{"key":"10.1016\/j.jare.2025.03.007_b0230","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1172\/JCI74915","article-title":"FGF21 is an endocrine signal of protein restriction","volume":"124","author":"Laeger","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jare.2025.03.007_b0235","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.molmet.2014.09.008","article-title":"Fructose ingestion acutely stimulates circulating FGF21 levels in humans","volume":"4","author":"Dushay","year":"2015","journal-title":"Mol Metab"},{"key":"10.1016\/j.jare.2025.03.007_b0240","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.tem.2010.11.003","article-title":"FGF21 reloaded: challenges of a rapidly growing field","volume":"22","author":"Kharitonenkov","year":"2011","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.jare.2025.03.007_b0245","doi-asserted-by":"crossref","first-page":"10853","DOI":"10.1073\/pnas.0904187106","article-title":"FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response","volume":"106","author":"Potthoff","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jare.2025.03.007_b0250","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.2337\/db14-0541","article-title":"FGF21 maintains glucose homeostasis by mediating the cross talk between liver and brain during prolonged fasting","volume":"63","author":"Liang","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.jare.2025.03.007_b0255","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.febslet.2008.04.038","article-title":"FGF21 attenuates lipolysis in human adipocytes - a possible link to improved insulin sensitivity","volume":"582","author":"Arner","year":"2008","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jare.2025.03.007_b0260","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.2337\/db05-1435","article-title":"Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1\/2 and Akt signaling pathways","volume":"55","author":"Wente","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.jare.2025.03.007_b0265","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.cmet.2017.03.005","article-title":"FGF21 regulates metabolism through adipose-dependent and -independent mechanisms","volume":"25","author":"BonDurant","year":"2017","journal-title":"Cell Metab"},{"key":"10.1016\/j.jare.2025.03.007_b0270","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1146\/annurev-nutr-071816-064800","article-title":"Fibroblast growth factor 21: a versatile regulator of metabolic homeostasis","volume":"38","author":"BonDurant","year":"2018","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.jare.2025.03.007_b0275","doi-asserted-by":"crossref","first-page":"15180","DOI":"10.1096\/fj.202001246RR","article-title":"Time-restricted feeding alleviates cardiac dysfunction induced by simulated microgravity via restoring cardiac FGF21 signaling","volume":"34","author":"Wang","year":"2020","journal-title":"FASEB J"},{"key":"10.1016\/j.jare.2025.03.007_b0280","doi-asserted-by":"crossref","first-page":"6018","DOI":"10.1210\/en.2008-0816","article-title":"Fibroblast growth factor 21 corrects obesity in mice","volume":"149","author":"Coskun","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.jare.2025.03.007_b0285","doi-asserted-by":"crossref","first-page":"4084","DOI":"10.1210\/en.2009-0221","article-title":"Fibroblast growth factor 21 controls glycemia via regulation of hepatic glucose flux and insulin sensitivity","volume":"150","author":"Berglund","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.jare.2025.03.007_b0290","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1016\/S0140-6736(18)31785-9","article-title":"Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial","volume":"392","author":"Sanyal","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jare.2025.03.007_b0295","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nature07201","article-title":"Origin and physiological roles of inflammation","volume":"454","author":"Medzhitov","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jare.2025.03.007_b0300","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.2337\/db20-0209","article-title":"The effects of B1344, a novel fibroblast growth factor 21 analog, on nonalcoholic steatohepatitis in nonhuman primates","volume":"69","author":"Cui","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.jare.2025.03.007_b0305","doi-asserted-by":"crossref","first-page":"e8791","DOI":"10.15252\/emmm.201708791","article-title":"FGF21 gene therapy as treatment for obesity and insulin resistance","volume":"10","author":"Jimenez","year":"2018","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.jare.2025.03.007_b0310","doi-asserted-by":"crossref","first-page":"6425","DOI":"10.1002\/jcp.26429","article-title":"Macrophage plasticity, polarization, and function in health and disease","volume":"233","author":"Shapouri-Moghaddam","year":"2018","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.jare.2025.03.007_b0315","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.intimp.2016.05.026","article-title":"Fibroblast growth factor 21 (FGF21) inhibits macrophage-mediated inflammation by activating Nrf2 and suppressing the NF-kappaB signaling pathway","volume":"38","author":"Yu","year":"2016","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jare.2025.03.007_b0320","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s10753-018-0729-3","article-title":"FGF-21 elevated IL-10 production to correct LPS-induced inflammation","volume":"41","author":"Li","year":"2018","journal-title":"Inflammation"},{"key":"10.1016\/j.jare.2025.03.007_b0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107634","article-title":"FGF21 alleviates chronic inflammatory injury in the aging process through modulating polarization of macrophages","volume":"96","author":"Kang","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jare.2025.03.007_b0330","doi-asserted-by":"crossref","first-page":"14254","DOI":"10.1096\/fj.201901347RR","article-title":"KLF15-activating Twist2 ameliorated hepatic steatosis by inhibiting inflammation and improving mitochondrial dysfunction via NF-kappaB-FGF21 or SREBP1c-FGF21 pathway","volume":"33","author":"Zhou","year":"2019","journal-title":"FASEB J"},{"key":"10.1016\/j.jare.2025.03.007_b0335","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.atherosclerosis.2019.08.017","article-title":"Inhibition of vascular neointima hyperplasia by FGF21 associated with FGFR1\/Syk\/NLRP3 inflammasome pathway in diabetic mice","volume":"289","author":"Wei","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jare.2025.03.007_b0340","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1002\/cbin.11409","article-title":"Overexpression of fibroblast growth factor-21 (FGF-21) protects mesenchymal stem cells against caspase-dependent apoptosis induced by oxidative stress and inflammation","volume":"44","author":"Linares","year":"2020","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.jare.2025.03.007_b0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106219","article-title":"Fibroblast growth factor 21 dependent TLR4\/MYD88\/NF-kappaB signaling activation is involved in lipopolysaccharide-induced acute lung injury","volume":"80","author":"Gao","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jare.2025.03.007_b0350","doi-asserted-by":"crossref","first-page":"e3018","DOI":"10.1038\/cddis.2017.410","article-title":"Cardioprotective effects of fibroblast growth factor 21 against doxorubicin-induced toxicity via the SIRT1\/LKB1\/AMPK pathway","volume":"8","author":"Wang","year":"2017","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jare.2025.03.007_b0355","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s10735-021-10011-3","article-title":"Elabela prevents angiotensin II-induced apoptosis and inflammation in rat aortic adventitial fibroblasts via the activation of FGF21-ACE2 signaling","volume":"52","author":"Song","year":"2021","journal-title":"J Mol Histol"},{"key":"10.1016\/j.jare.2025.03.007_b0360","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3892\/mmr.2021.12551","article-title":"FGF21 attenuates high uric acid-induced endoplasmic reticulum stress, inflammation and vascular endothelial cell dysfunction by activating Sirt1","volume":"25","author":"Ouyang","year":"2022","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.jare.2025.03.007_b0365","doi-asserted-by":"crossref","first-page":"4702","DOI":"10.1007\/s12035-017-0663-7","article-title":"FGF21 attenuates high-fat diet-induced cognitive impairment via metabolic regulation and anti-inflammation of obese mice","volume":"55","author":"Wang","year":"2018","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.jare.2025.03.007_b0370","first-page":"4750","article-title":"An engineered FGF21 variant, LY2405319, can prevent non-alcoholic steatohepatitis by enhancing hepatic mitochondrial function","volume":"8","author":"Lee","year":"2016","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.jare.2025.03.007_b0375","doi-asserted-by":"crossref","first-page":"31026","DOI":"10.1038\/srep31026","article-title":"Fibroblast growth factor 21 deficiency exacerbates chronic alcohol-induced hepatic steatosis and injury","volume":"6","author":"Liu","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jare.2025.03.007_b0380","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12944-016-0381-6","article-title":"Fibroblast growth factor 21 potentially inhibits microRNA-33 expression to affect macrophage actions","volume":"15","author":"Guo","year":"2016","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.jare.2025.03.007_b0385","first-page":"3417","article-title":"Fibroblast growth factor 21 as a possible endogenous factor inhibits apoptosis in cardiac endothelial cells","volume":"123","author":"Lu","year":"2010","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.jare.2025.03.007_b0390","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.bbrc.2015.02.104","article-title":"Endoplasmic reticulum stress induces up-regulation of hepatic \u03b2-Klotho expression through ATF4 signaling pathway","volume":"459","author":"Dong","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jare.2025.03.007_b0395","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1093\/abbs\/gmu097","article-title":"FGF21 treatment ameliorates alcoholic fatty liver through activation of AMPK-SIRT1 pathway","volume":"46","author":"Zhu","year":"2014","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"10.1016\/j.jare.2025.03.007_b0400","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1139\/cjpp-2014-0227","article-title":"Effects of fibroblast growth factor 21 on cell damage in vitro and atherosclerosis in vivo","volume":"92","author":"Zhu","year":"2014","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.jare.2025.03.007_b0405","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/cvr\/cvu263","article-title":"Fibroblast growth factor 21 protects the heart from oxidative stress","volume":"106","author":"Planavila","year":"2015","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jare.2025.03.007_b0410","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.biopha.2018.03.100","article-title":"FGF21 attenuates pulmonary fibrogenesis through ameliorating oxidative stress in vivo and in vitro","volume":"103","author":"Zhang","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jare.2025.03.007_b0415","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s11010-015-2358-6","article-title":"Fibroblast growth factor (FGF21) protects mouse liver against D-galactose-induced oxidative stress and apoptosis via activating Nrf2 and PI3K\/Akt pathways","volume":"403","author":"Yu","year":"2015","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.jare.2025.03.007_b0420","first-page":"1308","article-title":"Fibroblast growth factor 21 attenuates inflammation and oxidative stress in atherosclerotic rat via enhancing the Nrf1-ARE signaling pathway","volume":"11","author":"Jia","year":"2018","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.jare.2025.03.007_b0425","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1089\/ars.2010.3211","article-title":"Regulation of the Nrf2-Keap1 antioxidant response by the ubiquitin proteasome system: an insight into cullin-ring ubiquitin ligases","volume":"13","author":"Villeneuve","year":"2010","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.jare.2025.03.007_b0430","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.freeradbiomed.2020.03.014","article-title":"Manganese porphyrin, MnTE-2-PyP, treatment protects the prostate from radiation-induced fibrosis (RIF) by activating the NRF2 signaling pathway and enhancing SOD2 and sirtuin activity","volume":"152","author":"Shrishrimal","year":"2020","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jare.2025.03.007_b0435","article-title":"Fibroblast growth factor 21 protects against atrial remodeling via reducing oxidative stress","volume":"8","author":"Chen","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jare.2025.03.007_b0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102131","article-title":"Fibroblast growth factor 21 attenuates iron overload-induced liver injury and fibrosis by inhibiting ferroptosis","volume":"46","author":"Wu","year":"2021","journal-title":"Redox Biol"},{"key":"10.1016\/j.jare.2025.03.007_b0445","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1210\/en.2012-2276","article-title":"Fibroblast growth factor 21 improves insulin resistance and ameliorates renal injury in db\/db mice","volume":"154","author":"Kim","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.jare.2025.03.007_b0450","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1210\/en.2014-1619","article-title":"The protective effect of FGF21 on diabetes-induced male germ cell apoptosis is associated with up-regulated testicular AKT and AMPK\/Sirt1\/PGC-1alpha signaling","volume":"156","author":"Jiang","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.jare.2025.03.007_b0455","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1007\/s00125-015-3630-8","article-title":"Fibroblast growth factor 21 protects the heart from apoptosis in a diabetic mouse model via extracellular signal-regulated kinase 1\/2-dependent signalling pathway","volume":"58","author":"Zhang","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.jare.2025.03.007_b0460","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.jdiacomp.2018.05.012","article-title":"FGF21 protects human umbilical vein endothelial cells against high glucose-induced apoptosis via PI3K\/Akt\/Fox3a signaling pathway","volume":"32","author":"Guo","year":"2018","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.jare.2025.03.007_b0465","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1038\/srep02767","article-title":"Endocrine protection of ischemic myocardium by FGF21 from the liver and adipose tissue","volume":"3","author":"Liu","year":"2013","journal-title":"Sci Rep"},{"key":"10.1016\/j.jare.2025.03.007_b0470","doi-asserted-by":"crossref","first-page":"21843","DOI":"10.1074\/jbc.M109745200","article-title":"Akt enhances Mdm2-mediated ubiquitination and degradation of p53","volume":"277","author":"Ogawara","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jare.2025.03.007_b0475","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.bbadis.2019.01.019","article-title":"Fibroblast growth factor 21 protects the heart from angiotensin II-induced cardiac hypertrophy and dysfunction via SIRT1","volume":"1865","author":"Li","year":"2019","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.jare.2025.03.007_b0480","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12944-018-0846-x","article-title":"Fibroblast growth factor 21 inhibits atherosclerosis in apoE-\/- mice by ameliorating Fas-mediated apoptosis","volume":"17","author":"Yan","year":"2018","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.jare.2025.03.007_b0485","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s00380-014-0557-9","article-title":"Possible role of fibroblast growth factor 21 on atherosclerosis via amelioration of endoplasmic reticulum stress-mediated apoptosis in apoE(-\/-) mice","volume":"30","author":"Wu","year":"2015","journal-title":"Heart Vessels"},{"key":"10.1016\/j.jare.2025.03.007_b0490","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11010-016-2774-2","article-title":"FGF21 ameliorates nonalcoholic fatty liver disease by inducing autophagy","volume":"420","author":"Zhu","year":"2016","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.jare.2025.03.007_b0495","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.1111\/jcmm.15118","article-title":"FGF21 induces autophagy-mediated cholesterol efflux to inhibit atherogenesis via RACK1 up-regulation","volume":"24","author":"Xiaolong","year":"2020","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.jare.2025.03.007_b0500","first-page":"1321","article-title":"Fibroblast growth factor-21 alleviates hypoxia\/reoxygenation injury in H9c2 cardiomyocytes by promoting autophagic flux","volume":"43","author":"Ren","year":"2019","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.jare.2025.03.007_b0505","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/s41419-019-2105-0","article-title":"FGF21 augments autophagy in random-pattern skin flaps via AMPK signaling pathways and improves tissue survival","volume":"10","author":"Zhou","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jare.2025.03.007_b0510","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/bph.15701","article-title":"FGF21 promotes migration and differentiation of epidermal cells during wound healing via SIRT1-dependent autophagy","volume":"179","author":"Chen","year":"2022","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jare.2025.03.007_b0515","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1101\/gad.274142.115","article-title":"AMPK governs lineage specification through Tfeb-dependent regulation of lysosomes","volume":"30","author":"Young","year":"2016","journal-title":"Genes Dev"},{"key":"10.1016\/j.jare.2025.03.007_b0520","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nature18014","article-title":"AMPK-SKP2-CARM1 signalling cascade in transcriptional regulation of autophagy","volume":"534","author":"Shin","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jare.2025.03.007_b0525","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41467-020-14384-z","article-title":"Fasting-induced FGF21 signaling activates hepatic autophagy and lipid degradation via JMJD3 histone demethylase","volume":"11","author":"Byun","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.jare.2025.03.007_b0530","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087102","article-title":"Novel insights into the cardio-protective effects of FGF21 in lean and obese rat hearts","volume":"9","author":"Patel","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jare.2025.03.007_b0535","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ade4110","article-title":"An IL-6\/STAT3\/MR\/FGF21 axis mediates heart-liver cross-talk after myocardial infarction","volume":"9","author":"Sun","year":"2023","journal-title":"Sci Adv"},{"key":"10.1016\/j.jare.2025.03.007_b0540","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1093\/cvr\/cvx088","article-title":"Fgf21 is required for cardiac remodeling in pregnancy","volume":"113","author":"Redondo-Angulo","year":"2017","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jare.2025.03.007_b0545","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1177\/02676591221137482","article-title":"High serum fibroblast growth factor 21 levels were related to the prognosis and ventricular remodeling of heart failure patients with mildly reduced and reduced ejection fraction","volume":"39","author":"Fan","year":"2024","journal-title":"Perfusion-Uk"},{"key":"10.1016\/j.jare.2025.03.007_b0550","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1202730","article-title":"Mechanism of fibroblast growth factor 21 in cardiac remodeling","volume":"10","author":"Zhao","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jare.2025.03.007_b0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155535","article-title":"The association of circulating fibroblast growth factor 21 levels with incident heart failure: The Multi-Ethnic Study of Atherosclerosis","volume":"143","author":"Tucker","year":"2023","journal-title":"Metabolism"},{"key":"10.1016\/j.jare.2025.03.007_b0560","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1108234","article-title":"Fibroblast growth factor 21 and prognosis of patients with cardiovascular disease: A meta-analysis","volume":"14","author":"Yan","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jare.2025.03.007_b0565","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7138776","article-title":"Elevated serum fibroblast growth factor 21 is relevant to heart failure patients with reduced ejection fraction","volume":"2022","author":"Fan","year":"2022","journal-title":"Comput Math Methods Med"},{"key":"10.1016\/j.jare.2025.03.007_b0570","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s10741-020-09940-0","article-title":"Non-ischemic dilated cardiomyopathy and cardiac fibrosis","volume":"26","author":"Cojan-Minzat","year":"2021","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jare.2025.03.007_b0575","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/path.5226","article-title":"Fibroblast growth factor-21 protects against fibrosis in hypertensive heart disease","volume":"248","author":"Ferrer-Curriu","year":"2019","journal-title":"J Pathol"},{"key":"10.1016\/j.jare.2025.03.007_b0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174470","article-title":"Fibroblast growth factor 21 inhibited inflammation and fibrosis after myocardial infarction via EGR1","volume":"910","author":"Li","year":"2021","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jare.2025.03.007_b0585","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-02795-4","article-title":"AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation","volume":"9","author":"G\u00e9linas","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jare.2025.03.007_b0590","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.bbadis.2019.01.019","article-title":"Fibroblast growth factor 21 protects the heart from angiotensin II-induced cardiac hypertrophy and dysfunction via SIRT1","volume":"1865","author":"Li","year":"2019","journal-title":"Biochim Biophys Acta (BBA) - Mol Basis Dis"},{"key":"10.1016\/j.jare.2025.03.007_b0595","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.cmet.2018.06.013","article-title":"A2A receptor activation attenuates hypertensive cardiac remodeling via promoting brown adipose tissue-derived FGF21","volume":"28","author":"Ruan","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/j.jare.2025.03.007_b0600","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41419-018-0307-5","article-title":"Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart","volume":"9","author":"Yang","year":"2018","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jare.2025.03.007_b0605","first-page":"103","article-title":"The roles of FGF21 in atherosclerosis pathogenesis","volume":"20","author":"Tabari","year":"2019","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.jare.2025.03.007_b0610","doi-asserted-by":"crossref","first-page":"7338","DOI":"10.1038\/s41598-022-10993-4","article-title":"Ketone body and FGF21 coordinately regulate fasting-induced oxidative stress response in the heart","volume":"12","author":"Kawakami","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jare.2025.03.007_b0615","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1042\/CS20170271","article-title":"FGF21 ameliorates diabetic cardiomyopathy by activating the AMPK-paraoxonase 1 signaling axis in mice","volume":"131","author":"Wu","year":"2017","journal-title":"Clin Sci"},{"key":"10.1016\/j.jare.2025.03.007_b0620","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/5171945","article-title":"The biological role of klotho protein in the development of cardiovascular diseases","volume":"2018","author":"Olejnik","year":"2018","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jare.2025.03.007_b0625","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijcard.2018.02.109","article-title":"Autophagic control of cardiac steatosis through FGF21 in obesity-associated cardiomyopathy","volume":"260","author":"Rup\u00e9rez","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jare.2025.03.007_b0630","first-page":"3677","article-title":"FGF21 protects myocardial ischemia-reperfusion injury through reduction of miR-145-mediated autophagy","volume":"10","author":"Hu","year":"2018","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.jare.2025.03.007_b0635","doi-asserted-by":"crossref","first-page":"7432","DOI":"10.1073\/pnas.0701600104","article-title":"\u03b2Klotho is required for metabolic activity of fibroblast growth factor 21","volume":"104","author":"Ogawa","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jare.2025.03.007_b0640","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1177\/002215549704500710","article-title":"Differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal human adult tissues","volume":"45","author":"Hughes","year":"1997","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.jare.2025.03.007_b0645","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41419-023-05842-9","article-title":"FGF21-FGFR1 controls mitochondrial homeostasis in cardiomyocytes by modulating the degradation of OPA1","volume":"14","author":"Yan","year":"2023","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jare.2025.03.007_b0650","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3892\/ijmm.2024.5378","article-title":"Ultrasound-targeted microbubble destruction technology delivering \u03b2-klotho to the heart enhances FGF21 sensitivity and attenuates heart remodeling post-myocardial infarction","volume":"53","author":"Yue","year":"2024","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.jare.2025.03.007_b0655","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e14952","article-title":"FGF21\/FGFR1-\u03b2-KL cascade in cardiomyocytes modulates angiogenesis and inflammation under metabolic stress","volume":"9","author":"Kaur","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.jare.2025.03.007_b0660","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.3892\/ijmm.2017.3140","article-title":"Fibroblast growth factor 21 protects rat cardiomyocytes from endoplasmic reticulum stress by promoting the fibroblast growth factor receptor 1-extracellular signal-regulated kinase 1\/2 signaling pathway","volume":"40","author":"Liang","year":"2017","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.jare.2025.03.007_b0665","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.freeradbiomed.2023.09.033","article-title":"FGF21 protects against doxorubicin-induced cardiotoxicity by inhibiting connexin 43 ubiquitination","volume":"208","author":"Huang","year":"2023","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jare.2025.03.007_b0670","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.121.008910","article-title":"FGF21 (fibroblast growth factor 21) defines a potential cardiohepatic signaling circuit in end-stage heart failure","volume":"15","author":"Sommakia","year":"2022","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jare.2025.03.007_b0675","doi-asserted-by":"crossref","first-page":"18292","DOI":"10.1038\/s41598-024-69356-w","article-title":"Brown adipose tissue-derived FGF21 mediates the cardioprotection of dexmedetomidine in myocardial ischemia\/reperfusion injury","volume":"14","author":"Ding","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.jare.2025.03.007_b0680","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.cmet.2018.04.002","article-title":"FGF21 prevents angiotensin II-induced hypertension and vascular dysfunction by activation of ACE2\/angiotensin-(1\u20137) axis in mice","volume":"27","author":"Pan","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/j.jare.2025.03.007_b0685","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.atherosclerosis.2005.10.005","article-title":"Impact of oxidized low density lipoprotein on vascular cells","volume":"185","author":"Galle","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jare.2025.03.007_b0690","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0022-2143(03)00148-3","article-title":"Apoptosis and oxidants in the heart","volume":"142","author":"Kumar","year":"2003","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.jare.2025.03.007_b0695","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24065339","article-title":"Role of terpenophenolics in modulating inflammation and apoptosis in cardiovascular diseases: a review","volume":"24","author":"Abdul Ghani","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jare.2025.03.007_b0700","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.freeradbiomed.2015.08.030","article-title":"Redox signaling: Potential arbitrator of autophagy and apoptosis in therapeutic response","volume":"89","author":"Zhang","year":"2015","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jare.2025.03.007_b0705","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/s41591-021-01425-3","article-title":"Efruxifermin in non-alcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a trial","volume":"27","author":"Harrison","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.jare.2025.03.007_b0710","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.cmet.2016.02.001","article-title":"A long-acting FGF21 molecule, PF-05231023, decreases body weight and improves lipid profile in non-human primates and type 2 diabetic subjects","volume":"23","author":"Talukdar","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/j.jare.2025.03.007_b0715","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s10741-019-09809-x","article-title":"A review of fibroblast growth factor 21 in diabetic cardiomyopathy","volume":"24","author":"Zhang","year":"2019","journal-title":"Heart Fail Rev"}],"container-title":["Journal of Advanced Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123225001481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2090123225001481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:16:58Z","timestamp":1768954618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2090123225001481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":143,"alternative-id":["S2090123225001481"],"URL":"https:\/\/doi.org\/10.1016\/j.jare.2025.03.007","relation":{},"ISSN":["2090-1232"],"issn-type":[{"value":"2090-1232","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functions of FGF21 and its role in cardiac hypertrophy","name":"articletitle","label":"Article Title"},{"value":"Journal of Advanced Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jare.2025.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of Cairo University.","name":"copyright","label":"Copyright"}]}}